Schedule 13D ownership disclosure

Sonnet BioTherapeutics Holdings, Inc.

Security class unavailable · CUSIP: 83548R105

Event date: 2020-04-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.4600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001185185-20-000507
Form type
SC 13D/A
Filer
Oz Rey LLC
CIK
CIK 1794761
Filed
Apr 21, 2020
Reporting period
Apr 01, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub